Trial intelligence / Profile preview

Pharmacokinetics of edoxaban with tamoxifen in women with breast cancer

2018-004450-24Phase 4Active

Sponsor
Tergooi MC
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of edoxaban in venous thromboembolism (VTE), sponsored by Tergooi MC. Started May 2019; status: active.

02

Drugs

edoxaban
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on 2018-004450-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-004450-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call